Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis
Titel:
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis
Auteur:
Bria, E. Milella, M. Cuppone, F. Novello, S. Ceribelli, A. Vaccaro, V. Sperduti, I. Gelibter, A. Scagliotti, G.V. Cognetti, F. Giannarelli, D.